CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, CVS Health (CVS) stood at $102.81, denoting a -1.59% move from the preceding trading day.
CVS - CVS Health Corp.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$104.54
DETAILS
HIGH:
$115.00
LOW:
$90.00
MEDIAN:
$106.00
CONSENSUS:
$104.54
UPSIDE:
1.68%
Stock News
Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”
Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS | CVS Price Prediction) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite.
Here's Why CVS Health (CVS) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Absurdly Cheap Dividend Stocks to Buy With $1,000 in July
The S&P 500 keeps climbing, up nearly 9% year to date, and yet a handful of large-cap dividend payers are trading like the bull market forgot they exist.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Up 14.81% in a Year, COWZ Proves You Don’t Need Apple
The Pacer US Cash Cows 100 ETF (CBOE: COWZ) is having a solid 2026, up 6.4% year to date and 14.81% over the past year through July 6. Yet a fund built expressly to own America's biggest cash machines holds zero shares of Apple, arguably the most famous cash generator on the planet. That contradiction is... Up 14.81% in a Year, COWZ Proves You Don't Need Apple
Are You Looking for a Top Momentum Pick? Why CVS Health (CVS) is a Great Choice
Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find out.
CVS Health to hold second quarter 2026 earnings conference call
WOONSOCKET, R.I., July 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 5, 2026, at 8:00 a.m.
CVS Health: The Surprising Healthcare Outlier
CVS Health Corporation has outperformed peers, overcoming industry headwinds through effective management and strategic execution. CVS delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low-double-digit investor returns. While Health Services and Insurance segments anticipate mid-single-digit growth, retail is set for gradual decline but with margin improvements.
CVS Health vs. UnitedHealth: Comparing Revenue Trends for These Healthcare Companies
UnitedHealth generates higher overall revenue, though CVS Health has occasionally narrowed the gap between the two companies. Both companies experienced steady quarter-over-quarter revenue expansion through late 2025 before posting slight sequential declines in early 2026.
Top 5 Non-AI S&P 500 Stock Picks for 2H 2026 That Have Surged in 1H
ADM, CASY, DVA, CVS and BEN top a list of five non-AI S&P 500 stocks that surged more than 30% in 1H 2026 and still show momentum for 2H.
Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs
Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS Health are playing an important role for patients.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Big 3: CVS, SLV, PLTR
@Theotrade 's Don Kaufman takes us through today's Big 3 and offers example trades for his picks. He first highlights CVS Health (CVS), saying the company's upside-driving potential is worth hoping on the train.
Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.
This relationship between inflation and value stocks' outperformance is often overlooked. Many investment experts mistakenly believe that a strong economy, not inflation, is the key to value stocks beating growth stocks.
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run?
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Magic Formula Showdown: Why CVS Beats Qualcomm and Valero for Retirees
Joel Greenblatt's Magic Formula, popularized in The Little Book That Beats the Market, ranks stocks on two factors: earnings yield (operating earnings divided by enterprise value) and return on capital (how efficiently a business converts invested dollars into profits).
CVS Just Turned Its 9,000 Pharmacies Into a GLP-1 Delivery Machine. 1 Top Wall Street Analyst Thinks That's a Reason to Buy the Stock
CVS Health announced a program to help patients get easier access to GLP-1 medicines. This initiative could lead to stronger revenue for the company.
CVS Health Foundation invests $1 million in Hartford nonprofits tackling community health needs
Local organizations receive Hometown Fund support to expand access to health care, food, housing and essential services HARTFORD, Conn., June 25, 2026 /PRNewswire/ -- The CVS Health Foundation is investing $1 million in grants through its Hometown Fund to 20 organizations that are making a difference for the Greater Hartford area every day.
CVS Health Foundation invests $1 million in Rhode Island nonprofits tackling community health needs
Local organizations receive Hometown Fund support to expand access to health care, food, housing and essential services WOONSOCKET, R.I., June 25, 2026 /PRNewswire/ -- The CVS Health Foundation is investing $1 million in grants through its Hometown Fund to 20 organizations that are making a difference for Rhode Islanders every day.
Price Targets
CVS Health price target raised to $113 from $107 at RBC Capital
$113.00
(was $104.83)
RBC Capital
CVS Health (CVS) PT Raised to $110 at Cantor Fitzgerald Post ChecksMember Login
$110.00
(was $102.08)
Cantor Fitzgerald
CVS Health price target raised to $103 from $85 at HSBC
$103.00
(was $102.28)
HSBC
CVS Health price target raised to $115 from $110 at Mizuho
$115.00
(was $95.93)
Mizuho Securities
CVS Health price target raised to $111 from $106 at Morgan Stanley
$111.00
(was $91.37)
Morgan Stanley
CVS Health price target raised to $108 from $102 at Truist
$108.00
(was $90.98)
Truist Financial
Piper Sandler Reiterates Overweight Rating on CVS Health (CVS)
$113.00
(was $90.98)
Jessica Tassan
·
Piper Sandler
CVS Health price target raised to $106 from $101 at Barclays
$106.00
(was $91.63)
Andrew Mok
·
Barclays
CVS Health price target raised to $110 from $102 at Mizuho
$110.00
(was $94.18)
Mizuho Securities
CVS Health price target raised to $106 from $93 at Morgan Stanley
$106.00
(was $97.85)
Morgan Stanley
CVS Health price target raised to $106 from $94 at Bernstein
$106.00
(was $95.15)
Bernstein
CVS Health price target raised to $107 from $90 at RBC Capital
$107.00
(was $86.56)
RBC Capital
CVS Health price target raised to $92 from $88 at Deutsche Bank
$92.00
(was $87.46)
Deutsche Bank
CVS Health price target raised to $102 from $98 at Truist
$102.00
(was $87.04)
Truist Financial
CVS Health price target raised to $101 from $93 at Barclays
$101.00
(was $86.86)
Andrew Mok
·
Barclays
CVS Health price target raised to $94 from $92 at Baird
$94.00
(was $77.62)
Robert W. Baird
Leerink Partners Reiterates Outperform Rating on CVS Health (CVS), partnership with Google Cloud "positive AI development"
$98.00
(was $79.49)
Michael Cherny
·
Leerink Partners
CVS Health price target lowered to $90 from $91 at Argus
$90.00
(was $73.20)
Argus Research
CVS Health price target raised to $91 from $87 at Bernstein
$91.00
(was $80.56)
Bernstein
CVS Health price target raised to $87 from $86 at Bernstein
$87.00
(was $80.84)
Bernstein